Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edesa Biotech (EDSA) Leases (2019 - 2022)

Edesa Biotech's Leases history spans 4 years, with the latest figure at $39037.0 for Q2 2022.

  • For Q2 2022, Leases fell 66.87% year-over-year to $39037.0; the TTM value through Jun 2022 reached $39037.0, down 66.87%, while the annual FY2021 figure was $96571.0, 39.65% down from the prior year.
  • Leases for Q2 2022 was $39037.0 at Edesa Biotech, down from $59863.0 in the prior quarter.
  • Across five years, Leases topped out at $213848.0 in Q4 2019 and bottomed at $39037.0 in Q2 2022.
  • The 4-year median for Leases is $134252.0 (2021), against an average of $127642.5.
  • The largest annual shift saw Leases dropped 26.03% in 2021 before it tumbled 66.87% in 2022.
  • A 4-year view of Leases shows it stood at $213848.0 in 2019, then decreased by 29.66% to $150413.0 in 2020, then plummeted by 48.17% to $77964.0 in 2021, then crashed by 49.93% to $39037.0 in 2022.
  • Per Business Quant, the three most recent readings for EDSA's Leases are $39037.0 (Q2 2022), $59863.0 (Q1 2022), and $77964.0 (Q4 2021).